Webinar
on demand
17
Dec
2024
18
00
CET
Tumour sites CME accredited
Immunotherapy and GI cancer. Learnings from the ESMO Congress 2024, ESMO Immuno-Oncology Congress 2024 and Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024
Gastrointestinal (GI) cancers are among the most common and deadly worldwide. Recent advancements in minimally invasive surgery, targeted therapies, and immunotherapy are improving survival rates. Molecular insights are driving personalised treatment approaches, significantly enhancing patient outcomes. This webinar will explore these breakthroughs and future directions in GI cancer care.
Speakers
Discussant
Eric Van Cutsem
University of Leuven, Leuven, Belgium
Expert
Cindy Neuzillet
Institut Curie, Saint-Cloud, France
Expert
Erika Ruiz-Garcia
National Cancer Institute, Mexico City, Mexico